- Home
- ADXN vs DSS Comparison
ADXN vs DSS Comparison
Compare ADXN & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- DSS
- Stock Information
- Founded
- ADXN 2002
- DSS 1984
- Country
- ADXN Switzerland
- DSS United States
- Employees
- ADXN N/A
- DSS N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- ADXN Health Care
- DSS Consumer Discretionary
- Exchange
- ADXN Nasdaq
- DSS Nasdaq
- Market Cap
- ADXN 8.2M
- DSS 7.3M
- IPO Year
- ADXN N/A
- DSS N/A
- Fundamental
- Price
- ADXN $7.45
- DSS $0.93
- Analyst Decision
- ADXN Strong Buy
- DSS
- Analyst Count
- ADXN 1
- DSS 0
- Target Price
- ADXN $30.00
- DSS N/A
- AVG Volume (30 Days)
- ADXN 7.7K
- DSS 83.2K
- Earning Date
- ADXN 04-07-2025
- DSS 03-31-2025
- Dividend Yield
- ADXN N/A
- DSS N/A
- EPS Growth
- ADXN N/A
- DSS N/A
- EPS
- ADXN 0.06
- DSS N/A
- Revenue
- ADXN $701,260.00
- DSS $19,097,000.00
- Revenue This Year
- ADXN N/A
- DSS N/A
- Revenue Next Year
- ADXN N/A
- DSS N/A
- P/E Ratio
- ADXN $0.89
- DSS N/A
- Revenue Growth
- ADXN N/A
- DSS N/A
- 52 Week Low
- ADXN $6.67
- DSS $0.77
- 52 Week High
- ADXN $27.90
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- ADXN 47.90
- DSS 51.43
- Support Level
- ADXN $7.16
- DSS $0.78
- Resistance Level
- ADXN $8.05
- DSS $1.03
- Average True Range (ATR)
- ADXN 0.45
- DSS 0.11
- MACD
- ADXN -0.02
- DSS -0.00
- Stochastic Oscillator
- ADXN 51.22
- DSS 46.16
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.